The administration of Pfizer BioNTech COVID-19 vaccine to children under the age of 12 will begin in 2022.
The Ministry of Health (MoH) said that currently, only the Pfizer-BioNTech COVID-19 vaccine is available for use in children below 12 and it is awaiting regulatory approval from the European Union and the United States.
Photo via The Star
“Pfizer is also expected to submit data related to the vaccine registration for us in children below the age of 12 by the end of this year by the NPRA (National Pharmaceutical Regulatory Agency) for evaluation and approval,” the ministry said as reported by BERNAMA.
The government is currently in the process of procuring the Pfizer BioNTech vaccine for the group as it has a different formulation than those used for the adult population, subject to approvals from NPRA and the Drug Control Authority.
A total of 5.9 million children are expected to be inoculated against COVID-19 involving an estimated 11.8 million doses of vaccine.
Have you registered for the COVID-19 vaccine yet? Remember that it’s important that you keep yourself and others safe from the coronavirus. We’re all in this together, guys!
Herd immunity, here we come!
By: Aishah Akashah Ahadiat
